Related Experiment Video

Updated: Sep 14, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.6K

IFN-α2b Modulates GATA3 Expression to Inhibit Proliferation and Promote Apoptosis in KSHV-Infected Cells

Wumei Yuan1,2, Jun Zheng1, Lishu Zheng3,4

  • 1Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China.

Journal of Medical Virology
|July 24, 2025
PubMed

Insights

Interferon-alfa2b (IFN-α2b) inhibits Kaposi's sarcoma by suppressing LANA expression and enhancing GATA3. This research clarifies interferon's tumor-suppressing mechanisms for improved cancer therapy.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Interferon (IFN) demonstrates anti-tumor properties, particularly in virus-associated cancers.
  • The precise molecular pathways of IFN's anti-cancer effects require further elucidation.
  • Kaposi's sarcoma (KS) is a significant area of research for viral oncogenesis and therapeutic intervention.

Purpose of the Study:

  • To investigate the molecular mechanisms by which interferon-alfa2b (IFN-α2b) inhibits Kaposi's sarcoma (KS).
  • To identify key molecular targets and pathways regulated by IFN-α2b in KS.
  • To provide insights for enhancing the therapeutic efficacy of IFN-α2b against KS.

Main Methods:

  • Studied the effect of IFN-α2b on KSHV-infected cells.
  • Assessed LANA expression levels in response to IFN-α2b treatment.
  • Investigated the role of GATA3 and STAT5B phosphorylation in IFN-α2b-mediated inhibition.
  • Utilized cell proliferation and apoptosis assays.

Main Results:

  • IFN-α2b significantly suppressed LANA expression in KSHV-infected cells.
  • IFN-α2b treatment led to reduced cell proliferation and increased apoptosis in KS cells.
  • IFN-α2b was found to enhance GATA3 expression.
  • Overexpression of GATA3 inhibited STAT5B phosphorylation, indicating a regulatory role.

Conclusions:

  • IFN-α2b inhibits Kaposi's sarcoma progression through the regulation of GATA3 expression.
  • The observed effects involve the suppression of LANA and modulation of cell signaling pathways.
  • Further research into IFN-α2b interactions may reveal additional anti-cancer mechanisms.
Keywords:
GATA‐binding protein 3IFN‐α2bKaposi's Sarcomaapoptosisproliferation

More Related Videos

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.1K
Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells06:21

Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

12.6K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K